Ma Lianghua, Li Guang, Wei Minjie
Department of Radiation Oncology, The First Affiliated Hospital of China Medical University, Shenyang 110001, People's Republic of China.
Department of Pharmacology, School of Pharmaceutical Science, China Medical University, Shenyang 110122, People's Republic of China.
Cancer Manag Res. 2020 Sep 30;12:9429-9434. doi: 10.2147/CMAR.S267523. eCollection 2020.
To explore whether the neutrophil-to-lymphocyte ratio (NLR) and its changes are related to tumor recurrence in grade II-IV glioma patients.
One hundred patients who underwent two surgeries (first for diagnosis and the second for recurrence) were retrospectively analyzed. Complete blood count was obtained preoperatively before any treatment. Basic NLR (before the first surgery) and NLR changes were calculated. Tumor recurrence was evaluated by progression-free survival (PFS) using the Kaplan-Meier method. Univariate and multivariate Cox regression analyses were used to determine the potential prognostic factors for PFS.
The PFS of patients with high basic NLR (≥4) (median 9 months) was shorter than that of patients with low basic NLR (<4) (median 23 months) ( = 0.004). Univariate and multivariate analyses both showed that basic NLR (before the first surgery) (≥4 vs <4) was an independent predictor of PFS ( = 0.011). The PFS is also varied with NLR changes before two surgeries ( < 0.05). The PFS of patients with two low NLR (<4) at both initial surgical resection and section for tumor recurrence had the longest PSF. The patients with two high NLR (≥4) at both initial surgical resection and section for tumor recurrence had the shortest PSF. The patients with one high NLR (≥4) at initial surgical resection or section for tumor recurrence had an average PSF. Multivariate analysis showed that the change of NLR was of prognostic significance independent of glioma grade.
We showed both basic NLR and NLR changes could predict the recurrence of glioma, but the change of NLR is more accurate than that of basic NLR. The current research not only provides a simple and feasible method for clinical judgment of glioma recurrence but also provides a new idea for exploring the mechanism of glioma recurrence.
探讨中性粒细胞与淋巴细胞比值(NLR)及其变化是否与II-IV级胶质瘤患者的肿瘤复发相关。
回顾性分析100例行两次手术(首次手术用于诊断,第二次手术用于复发)的患者。在任何治疗前术前获取全血细胞计数。计算基础NLR(首次手术前)和NLR变化。采用Kaplan-Meier法通过无进展生存期(PFS)评估肿瘤复发情况。使用单因素和多因素Cox回归分析确定PFS的潜在预后因素。
基础NLR高(≥4)的患者的PFS(中位数9个月)短于基础NLR低(<4)的患者(中位数23个月)(P = 0.004)。单因素和多因素分析均显示,首次手术前的基础NLR(≥4 vs <4)是PFS的独立预测因素(P = 0.011)。PFS也随两次手术前NLR的变化而变化(P<0.05)。在初始手术切除和肿瘤复发切除时NLR均低(<4)的患者的PFS最长。在初始手术切除和肿瘤复发切除时NLR均高(≥4)的患者的PFS最短。在初始手术切除或肿瘤复发切除时NLR高(≥4)的患者的PFS为中等。多因素分析显示,NLR的变化独立于胶质瘤分级具有预后意义。
我们发现基础NLR和NLR变化均可预测胶质瘤复发,但NLR变化比基础NLR更准确。本研究不仅为胶质瘤复发的临床判断提供了一种简单可行的方法,也为探索胶质瘤复发机制提供了新思路。